QQQ   284.74 (+0.20%)
AAPL   115.04 (-0.61%)
MSFT   216.23 (+0.62%)
FB   284.79 (+2.40%)
GOOGL   1,632.98 (+1.64%)
AMZN   3,204.40 (+0.88%)
TSLA   420.63 (-1.21%)
NVDA   543.61 (+1.72%)
BABA   309.92 (+1.19%)
CGC   19.73 (-2.81%)
GE   7.63 (-1.17%)
MU   52.85 (-2.81%)
AMD   81.96 (+3.20%)
T   27.82 (-1.63%)
F   8.16 (-0.61%)
ACB   4.68 (-3.51%)
GILD   60.79 (+0.20%)
NFLX   488.28 (+0.63%)
BA   167.36 (-1.01%)
NIO   27.16 (-0.80%)
DIS   128.35 (+0.62%)
QQQ   284.74 (+0.20%)
AAPL   115.04 (-0.61%)
MSFT   216.23 (+0.62%)
FB   284.79 (+2.40%)
GOOGL   1,632.98 (+1.64%)
AMZN   3,204.40 (+0.88%)
TSLA   420.63 (-1.21%)
NVDA   543.61 (+1.72%)
BABA   309.92 (+1.19%)
CGC   19.73 (-2.81%)
GE   7.63 (-1.17%)
MU   52.85 (-2.81%)
AMD   81.96 (+3.20%)
T   27.82 (-1.63%)
F   8.16 (-0.61%)
ACB   4.68 (-3.51%)
GILD   60.79 (+0.20%)
NFLX   488.28 (+0.63%)
BA   167.36 (-1.01%)
NIO   27.16 (-0.80%)
DIS   128.35 (+0.62%)
QQQ   284.74 (+0.20%)
AAPL   115.04 (-0.61%)
MSFT   216.23 (+0.62%)
FB   284.79 (+2.40%)
GOOGL   1,632.98 (+1.64%)
AMZN   3,204.40 (+0.88%)
TSLA   420.63 (-1.21%)
NVDA   543.61 (+1.72%)
BABA   309.92 (+1.19%)
CGC   19.73 (-2.81%)
GE   7.63 (-1.17%)
MU   52.85 (-2.81%)
AMD   81.96 (+3.20%)
T   27.82 (-1.63%)
F   8.16 (-0.61%)
ACB   4.68 (-3.51%)
GILD   60.79 (+0.20%)
NFLX   488.28 (+0.63%)
BA   167.36 (-1.01%)
NIO   27.16 (-0.80%)
DIS   128.35 (+0.62%)
QQQ   284.74 (+0.20%)
AAPL   115.04 (-0.61%)
MSFT   216.23 (+0.62%)
FB   284.79 (+2.40%)
GOOGL   1,632.98 (+1.64%)
AMZN   3,204.40 (+0.88%)
TSLA   420.63 (-1.21%)
NVDA   543.61 (+1.72%)
BABA   309.92 (+1.19%)
CGC   19.73 (-2.81%)
GE   7.63 (-1.17%)
MU   52.85 (-2.81%)
AMD   81.96 (+3.20%)
T   27.82 (-1.63%)
F   8.16 (-0.61%)
ACB   4.68 (-3.51%)
GILD   60.79 (+0.20%)
NFLX   488.28 (+0.63%)
BA   167.36 (-1.01%)
NIO   27.16 (-0.80%)
DIS   128.35 (+0.62%)
Log in
NYSE:PEN

Penumbra Stock Forecast, Price & News

$236.00
+5.68 (+2.47 %)
(As of 10/23/2020 04:15 PM ET)
Add
Compare
Today's Range
$228.47
Now: $236.00
$236.09
50-Day Range
$186.92
MA: $202.63
$219.41
52-Week Range
$121.80
Now: $236.00
$241.81
Volume369,770 shs
Average Volume359,290 shs
Market Capitalization$8.52 billion
P/E Ratio813.82
Dividend YieldN/A
Beta0.67
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, Japan, and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; rehabilitation tools that displays and tracks upper-extremity rehabilitation exercises under the REAL Immersive System brand name; aspiration-based thrombectomy systems for vascular applications under the Indigo System brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and detachable, microcatheter-deliverable occlusion devices designed primarily to occlude peripheral vessels under the POD (Penumbra Occlusion Device) brand name, as well as a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and POD Packing Coil brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was founded in 2004 and is headquartered in Alameda, California.
Read More
Penumbra logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.4Community Rank: 3.8Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.56 out of 5 stars

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone510-748-3200
Employees2,700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$547.41 million
Cash Flow$1.38 per share
Book Value$13.91 per share

Profitability

Net Income$48.46 million

Miscellaneous

Market Cap$8.52 billion
Next Earnings Date10/28/2020 (Confirmed)
OptionableOptionable
$236.00
+5.68 (+2.47 %)
(As of 10/23/2020 04:15 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PEN News and Ratings via Email

Sign-up to receive the latest news and ratings for PEN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Penumbra (NYSE:PEN) Frequently Asked Questions

How has Penumbra's stock been impacted by COVID-19?

Penumbra's stock was trading at $176.86 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, PEN stock has increased by 33.4% and is now trading at $236.00.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Penumbra?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Penumbra in the last year. There are currently 2 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Penumbra
.

When is Penumbra's next earnings date?

Penumbra is scheduled to release its next quarterly earnings announcement on Wednesday, October 28th 2020.
View our earnings forecast for Penumbra
.

How can I listen to Penumbra's earnings call?

Penumbra will be holding an earnings conference call on Wednesday, October 28th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Penumbra's earnings last quarter?

Penumbra, Inc. (NYSE:PEN) announced its quarterly earnings results on Monday, August, 3rd. The company reported ($0.30) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.39) by $0.09. The business had revenue of $105.11 million for the quarter, compared to analysts' expectations of $100.75 million. Penumbra had a return on equity of 1.25% and a net margin of 2.02%. The business's revenue was down 21.7% compared to the same quarter last year. During the same period in the prior year, the business earned $0.27 EPS.
View Penumbra's earnings history
.

What price target have analysts set for PEN?

8 brokerages have issued 12 month price objectives for Penumbra's stock. Their forecasts range from $192.00 to $264.00. On average, they expect Penumbra's share price to reach $232.83 in the next twelve months. This suggests that the stock has a possible downside of 1.3%.
View analysts' price targets for Penumbra
.

Are investors shorting Penumbra?

Penumbra saw a increase in short interest during the month of September. As of September 30th, there was short interest totaling 3,800,000 shares, an increase of 21.4% from the September 15th total of 3,130,000 shares. Based on an average daily trading volume, of 335,000 shares, the short-interest ratio is currently 11.3 days. Approximately 11.3% of the company's shares are sold short.
View Penumbra's Short Interest
.

Who are some of Penumbra's key competitors?

What other stocks do shareholders of Penumbra own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Penumbra investors own include NVIDIA (NVDA), Intuitive Surgical (ISRG), AbbVie (ABBV), Tesla (TSLA), Alibaba Group (BABA), Johnson & Johnson (JNJ), Netflix (NFLX), UnitedHealth Group (UNH), The Boeing (BA) and DexCom (DXCM).

Who are Penumbra's key executives?

Penumbra's management team includes the following people:
  • Mr. Adam Elsesser, Co-Founder, Chairman, Pres & CEO (Age 58, Pay $726.69k)
  • Ms. Maggie S. Yuen, Chief Financial Officer (Age 48, Pay $643.64k)
  • Ms. Johanna Roberts, Exec. VP, Gen. Counsel & Sec. (Age 48, Pay $530.92k)
  • Mr. James Robert Pray, Pres of International (Age 56, Pay $504.29k)
  • Ms. Lynn Rothman, Exec. VP & Chief Bus. Officer (Age 59, Pay $605.13k)

What is Penumbra's stock symbol?

Penumbra trades on the New York Stock Exchange (NYSE) under the ticker symbol "PEN."

Who are Penumbra's major shareholders?

Penumbra's stock is owned by a variety of retail and institutional investors. Top institutional investors include Retirement Systems of Alabama (0.12%), Regis Management CO LLC (0.03%), Louisiana State Employees Retirement System (0.02%), Pacer Advisors Inc. (0.02%), Envestnet Asset Management Inc. (0.02%) and State of Alaska Department of Revenue (0.02%). Company insiders that own Penumbra stock include Adam Elsesser, Arani Bose, Bridget O'rourke, Coyne David, Don W Kassing, Harpreet Grewal, James Robert Pray, Johanna Roberts, Lynn Rothman, Sridhar Kosaraju and Thomas Wilder.
View institutional ownership trends for Penumbra
.

Which major investors are selling Penumbra stock?

PEN stock was sold by a variety of institutional investors in the last quarter, including Mission Wealth Management LP, Polaris Wealth Advisory Group LLC, CENTRAL TRUST Co, Envestnet Asset Management Inc., and State of Alaska Department of Revenue. Company insiders that have sold Penumbra company stock in the last year include Adam Elsesser, Arani Bose, Bridget O'rourke, Don W Kassing, James Robert Pray, Johanna Roberts, Lynn Rothman, Sridhar Kosaraju, and Thomas Wilder.
View insider buying and selling activity for Penumbra
.

Which major investors are buying Penumbra stock?

PEN stock was acquired by a variety of institutional investors in the last quarter, including Regis Management CO LLC, Pacer Advisors Inc., Candriam Luxembourg S.C.A., Spearhead Capital Advisors LLC, NuWave Investment Management LLC, IBM Retirement Fund, Retirement Systems of Alabama, and Nisa Investment Advisors LLC.
View insider buying and selling activity for Penumbra
.

How do I buy shares of Penumbra?

Shares of PEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Penumbra's stock price today?

One share of PEN stock can currently be purchased for approximately $236.00.

How big of a company is Penumbra?

Penumbra has a market capitalization of $8.52 billion and generates $547.41 million in revenue each year. The company earns $48.46 million in net income (profit) each year or $0.98 on an earnings per share basis. Penumbra employs 2,700 workers across the globe.

What is Penumbra's official website?

The official website for Penumbra is www.penumbrainc.com.

How can I contact Penumbra?

Penumbra's mailing address is One Penumbra Place, Alameda CA, 94502. The company can be reached via phone at 510-748-3200 or via email at [email protected]

This page was last updated on 10/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.